← Back to All US Stocks

HYPD Stock Analysis 2026 - HYPERION DEFI, INC. AI Rating

HYPD Nasdaq Pharmaceutical Preparations DE CIK: 0001682639
Recently Updated • Analysis: Apr 11, 2026 • SEC Data: 2025-12-31
STRONG SELL
85% Conf
Pending
Analysis scheduled

📊 HYPD Key Takeaways

Revenue: $813.5K
Net Margin: -5,570.6%
Free Cash Flow: $-14.8M
Current Ratio: 2.68x
Debt/Equity: 0.18x
EPS: $-9.40
AI Rating: STRONG SELL with 85% confidence

Is HYPD a Good Investment? Thesis Analysis

Claude

Company faces imminent liquidity crisis with only ~5 months of cash runway ($6.4M cash vs. $14.8M annual operating burn). Despite 1318.8% revenue growth, the cost structure is fundamentally broken: $56.7M+ operating expenses generating just $813.5K revenue is unsustainable. Without immediate capital infusion or dramatic restructuring, insolvency risk is high.

Why Buy HYPD? Key Strengths

Claude
  • + Strong gross margin of 62.7% indicates potential unit economics and profitability at scale
  • + Exceptional revenue growth rate of 1318.8% YoY suggests emerging product market traction
  • + Conservative leverage with 0.18x debt/equity ratio limits financial obligations

HYPD Investment Risks to Consider

Claude
  • ! Critical solvency risk: approximately 5 months of cash runway at current burn rate
  • ! Completely unsustainable operating expense structure ($56.7M operating costs on $813.5K revenue)
  • ! Negative operating cash flow of $14.8M with no clear path to profitability without major catalyst
  • ! Company requires immediate external financing or faces near-term bankruptcy

Key Metrics to Watch

Claude
  • * Monthly cash burn rate and remaining cash runway
  • * Revenue trajectory required to reach operating break-even (currently needs 50x+ growth)
  • * Operating expense reduction initiatives and management restructuring plans
  • * Capital raise announcements or partnership/acquisition activity

HYPD Financial Metrics

Revenue
$813.5K
Net Income
$-45.3M
EPS (Diluted)
$-9.40
Free Cash Flow
$-14.8M
Total Assets
$51.8M
Cash Position
$6.4M

💡 AI Analyst Insight

Strong liquidity with a 2.68x current ratio provides a solid financial cushion.

HYPD Profitability Ratios

Gross Margin 62.7%
Operating Margin -5,743.5%
Net Margin -5,570.6%
ROE -110.4%
ROA -87.5%
FCF Margin -1,818.6%

HYPD vs Healthcare Sector

How HYPERION DEFI, INC. compares to Healthcare sector averages

Net Margin
HYPD -5,570.6%
vs
Sector Avg 12.0%
HYPD Sector
ROE
HYPD -110.4%
vs
Sector Avg 15.0%
HYPD Sector
Current Ratio
HYPD 2.7x
vs
Sector Avg 2.0x
HYPD Sector
Debt/Equity
HYPD 0.2x
vs
Sector Avg 0.6x
HYPD Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is HYPD Overvalued or Undervalued?

Based on fundamental analysis, HYPERION DEFI, INC. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
-110.4%
Sector avg: 15%
Net Profit Margin
-5,570.6%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.18x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

HYPD Balance Sheet & Liquidity

Current Ratio
2.68x
Quick Ratio
1.58x
Debt/Equity
0.18x
Debt/Assets
20.7%
Interest Coverage
-122.95x
Long-term Debt
$7.5M

HYPD 5-Year Financial Trend & Growth Analysis

HYPD 5-year financial data: Year 2021: Revenue $14.0M, Net Income -$19.8M, EPS $-0.94. Year 2022: Revenue $14.0M, Net Income -$12.8M, EPS $-0.49. Year 2023: Revenue $3.8K, Net Income -$28.0M, EPS $-0.83. Year 2024: Revenue $57.3K, Net Income -$27.3M, EPS $-53.15. Year 2025: Revenue $813.5K, Net Income -$49.8M, EPS $-59.81.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: HYPERION DEFI, INC.'s revenue has declined by 94% over the 5-year period, indicating business contraction. The most recent EPS of $-59.81 indicates the company is currently unprofitable.

HYPD Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-1,818.6%
Free cash flow / Revenue

HYPD Quarterly Performance

Quarterly financial performance data for HYPERION DEFI, INC. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $1.6K -$3.5M $0.05
Q2 2025 $14.7K -$3.5M $-2.50
Q1 2025 $5.0K -$3.5M $-1.59
Q3 2024 $1.2K -$5.7M $-0.11
Q2 2024 $22.6K -$5.7M $-0.16
Q1 2024 $5.0K -$5.7M $-0.15
Q3 2023 $1.2K -$5.7M $-0.18
Q3 2022 N/A -$4.8M $-0.21

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

HYPD Capital Allocation

Operating Cash Flow
-$14.8M
Cash generated from operations
Capital Expenditures
$23.0K
Investment in assets
Dividends
None
No dividend program

HYPD SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for HYPERION DEFI, INC. (CIK: 0001682639)

📋 Recent SEC Filings

Date Form Document Action
Apr 1, 2026 4 xslF345X06/tm2610800-1_4seq2.xml View →
Mar 30, 2026 10-K hypd-20251231x10k.htm View →
Mar 26, 2026 8-K tm269775d1_8k.htm View →
Jan 12, 2026 4 xslF345X05/tm262924-2_4seq1.xml View →
Jan 5, 2026 8-K tm2534601d1_8k.htm View →

Frequently Asked Questions about HYPD

What is the AI rating for HYPD?

HYPERION DEFI, INC. (HYPD) has an AI rating of STRONG SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.

What are HYPD's key strengths?

Claude: Strong gross margin of 62.7% indicates potential unit economics and profitability at scale. Exceptional revenue growth rate of 1318.8% YoY suggests emerging product market traction.

What are the risks of investing in HYPD?

Claude: Critical solvency risk: approximately 5 months of cash runway at current burn rate. Completely unsustainable operating expense structure ($56.7M operating costs on $813.5K revenue).

What is HYPD's revenue and growth?

HYPERION DEFI, INC. reported revenue of $813.5K.

Does HYPD pay dividends?

HYPERION DEFI, INC. does not currently pay dividends.

Where can I find HYPD SEC filings?

Official SEC filings for HYPERION DEFI, INC. (CIK: 0001682639) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is HYPD's EPS?

HYPERION DEFI, INC. has a diluted EPS of $-9.40.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is HYPD a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, HYPERION DEFI, INC. has a STRONG SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is HYPD stock overvalued or undervalued?

Valuation metrics for HYPD: ROE of -110.4% (sector avg: 15%), net margin of -5,570.6% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy HYPD stock in 2026?

Our dual AI analysis gives HYPERION DEFI, INC. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is HYPD's free cash flow?

HYPERION DEFI, INC.'s operating cash flow is $-14.8M, with capital expenditures of $23.0K. FCF margin is -1,818.6%.

How does HYPD compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -5,570.6% (avg: 12%), ROE -110.4% (avg: 15%), current ratio 2.68 (avg: 2).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 11, 2026 | Data as of: 2025-12-31 | Powered by Claude AI